- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears Sonosite’s hand-held ultrasound
SonoSite of Bothell, WA, this month received premarket clearance for its digital hand-held ultrasound unit. The company announced April 5 that the Food and Drug Administration had cleared the device and that SonoSite would begin its marketing
SonoSite of Bothell, WA, this month received premarket clearance for its digital hand-held ultrasound unit. The company announced April 5 that the Food and Drug Administration had cleared the device and that SonoSite would begin its marketing efforts.
Last May, SonoSites prototype device received premarket clearance, which covered 11 clinical applications including obstetrical, gynecological, abdominal, and cardiovascular imaging (SCAN 5/13/98). The new clearance covers such updates to the prototype as increased signal processing ability, and adds transrectal imaging to the devices list of applications. SonoSites scanner will weigh less than 6 pounds and the firm expects to begin selling the units late this year.
The company moved quickly to establish distributor partnerships for the unit, announcing April 7 that it had signed an agreement with Esaote of Genoa, Italy. The agreement gives Esaote distribution rights for the new device in Germany, France, Italy, and the Netherlands.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
